We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Baxter Divests Dialysis Businesses

By HospiMedica staff writers
Posted on 21 Jul 2003
The divestiture of some renal therapy services (RTS) dialysis centers outside the United States and agreements to sell the company's US-based renal management Lifeline access management and disease management businesses has been announced by Baxter Healthcare Corp. (Deerfield, IL, USA).

Avitum Austria GmbH, a subsidiary of B. Braun (Melsungen, Germany), will acquire four renal care centers in Slovakia and the Czech Republic. Atvium will continue to work with Baxter to provide dialysis services in those countries. DaVita, Inc. (Torrance, CA, USA), will acquire the US-based Lifeline access and disease management businesses. Lifeline manages vascular access centers to meet the needs of end-stage renal disease (ESRD) patients.

"The sale of these service businesses allows Baxter to concentrate on our core products to improve renal care,” said Al Heller, senior vice president of Baxter. "In addition, these transactions provide us with the opportunity to continue building product sales based on our relationships with the buyers of these businesses.” In April 2003, Baxter completed the sale of its dialysis centers in Italy to a management group that had been operating them under contract. Baxter is currently analyzing offers for the remaining dialysis centers.




Related Links:
Baxter

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
12-Channel ECG
CM1200B
New
Mobile Barrier
Tilted Mobile Leaded Barrier
New
Ultrasonic Cleaner
Cole-Parmer Ultrasonic Cleaner with Digital Timer

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024